Back to top

Blog

The views and opinions expressed herein are those of the author and do not necessarily reflect those of BehaveNet, Inc.
Moviedoc's Favorite Quotes

Buvaya for Acute Pain

Posted on: 07/06/2018

An FDA panel has rejected the application for Buvaya sublingual buprenorphine spray. Their rationale? Risk of respiratory depression. FDA has rejected the safest opioid, buprenorphine, used around the world for treating acute pain and first approved in the U.S. for treating pain in injectable form in 1981 as Buprenex. The result? Prescribers will continue to turn to more dangerous and addictive hydrocodone, oxycodone and others, contributing to, instead of ameliorating, the opioid overdose crisis.